Error: Could not add to watchlist. X
+ Watchlist

NeurogesX Inc

NGSX:US
Ticker Delisted
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.917
Market Cap (USD)
-
Shares Outstanding (m)
33.333
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.21%
% Price Change
-0.28%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
NeurogesX, Inc. is a biopharmaceutical company. The Company develops treatments for chronic peripheral neuropathic pain including postherpetic neuralgia, painful HIV-distal sensory polyneuropathy, and painful diabetic neuropathy.
Address
2215 Bridgepointe Parkway
Suite 200
San Mateo, CA 94404
United States
Phone
1-650-508-2116
Show More